545 Results

People

  1. Motzer
    Motzer
  2. Bosl
    Bosl
  3. Sheinfeld
    Sheinfeld
  4. Yahalom
    Yahalom
  5. Bajorin
    Bajorin
  6. Straus
    Straus
  7. Feldman
    Feldman
  8. Kelsen
    Kelsen
  9. Moskowitz
    Moskowitz
  10. Herr
    Herr

Groups

  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)
  7. Genitourinary Oncology Service (91)
  8. Lymphoma (88)
  9. Urology (60)
  10. Radiation Oncology, Department of (58)
  1. "bleomycin"
Formats
  1. Journal Article (520)
  2. Conference Paper (11)
  3. Review (5)
  4. Editorial (3)
  5. Meeting Abstract (3)
  6. Book Section (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Department of Medicine (281)
  2. Survivorship Research (171)
  3. Solid Tumor Oncology Division (166)
  4. Surgery (130)
  5. Hematologic Malignancies, Division of (113)
  6. Center for Hematologic Malignancies (112)

More Groups

People
  1. George Bosl (85)
  2. Robert Motzer (59)
  3. Joel Sheinfeld (44)
  4. David Straus (41)
  5. Joachim Yahalom (39)
  6. Dean Bajorin (36)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (11)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Cancer (38)
  3. Seminars in Oncology (22)
  4. Gynecologic Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (18)
  6. International Journal of Radiation Oncology, Biology, Physics (12)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. American Society of Clinical Oncology (66)
  3. Wiley Blackwell (53)
  4. Lippincott Williams & Wilkins (32)
  5. Springer (28)
  6. Oxford University Press (24)

More Publishers

Results (545)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors
    Journal Article

    Matulewicz, R. S.; Baky, F.; Liso, N.; Williams, B. M.; Porwal, S.; Assel, M.; Carver, B. S.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
    Journal Article

    Ma, J.; Daou, R.; Bou Eid, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: A real world analysis from 15 U.S. academic centers
    Journal Article

    Voorhees, T. J.; McLaughlin, E. M.; Torka, P.; Florindez, J.; Kim, N. H.; Moyo, T. K.; Reves, H.; Sumransub, N.; Deshpande, S.; Rose, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Characterizing nodal gamma-delta t-cell lymphoma: Clinicopathological and molecular insights
    Journal Article

    Oon, M. L.; Lim, J. Q.; Bosch-Schips, J.; Climent, F.; Au-Yeung, R. K. H.; Hutchison, B.; Sohani, A. R.; Eren, O. C.; Kumar, J.; Dogan, A.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center
    Journal Article

    Liu, Y. L.; Praiss, A. M.; Chiang, S.; Devereaux, K.; Huang, J.; Rizzuto, G.; Al-Rawi, D.; Weigelt, B.; Jewell, E.; Abu-Rustum, N. R.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Postoperative adjuvant chemoradiotherapy versus postoperative adjuvant radiotherapy for head and neck squamous cell carcinoma with adverse pathology: A systematic review and meta-analysis
    Review

    Korczaguin, G. G.; Teixeira, G. V.; Shaha, A.
    Brazilian Journal of Otorhinolaryngology (2024)

    Fulltext@MSK | Save
  • Fifteen-year experience of a single institution: Outcomes for early-stage Hodgkins lymphoma comparing chemotherapy alone versus combined modality therapy
    Journal Article

    Qian, J. Y.; Amin, R.; Ali, H.; Cao, Y.; Switchenko, J. M.; Rashid, A. S.; Allen, P. B.; Hanasoge, S.; Khan, M. K.
    Advances in Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin as initial salvage chemotherapy for germ cell tumors: Long-term follow-up and outcomes for favorable- and unfavorable-risk disease
    Journal Article

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Bains, M.; Jones, D. R.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14
    Journal Article

    Brown, J.; Miller, A.; Holman, L. L.; Backes, F.; Nagel, C.; Bender, D.; Miller, D. S.; Powell, M. A.; Westin, S. N.; Bonebrake, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Combination chemotherapy for Hodgkin lymphoma
    Editorial

    Moskowitz, A. J.
    Haematologica (2024)

    Fulltext@MSK | Save